Schering-Plough Settles Claritin Kickback Investigation For $345.5 Mil.
This article was originally published in The Pink Sheet Daily
Executive Summary
Settlement stems from managed care contracts with Cigna and PacifiCare in 1998. “Data processing fees” were in fact disguised rebates that should have been reported to Medicaid, Schering acknowledges.
You may also be interested in...
“Whistleblower” Suits Should Be Encouraged By Rx Manufacturers, Sen. Grassley Says
Schering-Plough’s Claritin settlement prompts letter from Grassley to Schering and 18 other manufacturers. Educating employees about the False Claims Act and their right to file suit is a “step in the right direction” to address fraud, he says.
“Whistleblower” Suits Should Be Encouraged By Rx Manufacturers, Sen. Grassley Says
Schering-Plough’s Claritin settlement prompts letter from Grassley to Schering and 18 other manufacturers. Educating employees about the False Claims Act and their right to file suit is a “step in the right direction” to address fraud, he says.
Schering Corp. Accepts Federal Contract Ban Under Settlement
Schering Sales Corp. is accepting the ultimate penalty under the antikickback statute: a five-year ban from participating in federal government contracts